The Latin America, Middle East and Africa Pigmentation Disorder Treatment Market would witness market growth of 6.9% CAGR during the forecast period (2023-2030).
The rising incidence of pigmentation disorders, such as melasma, post-inflammatory hyperpigmentation, and age-related skin discoloration, has boosted the demand for effective treatment options. As the population ages, there is a higher demand for anti-aging and skin rejuvenation treatments, often including pigmentation disorder treatments.
Heightened awareness of the effects of sun exposure and pollution on skin health has led more individuals to seek treatment for pigmentation issues. Continued advancements in dermatological technology, including laser therapies, chemical peels, and topical treatments, have made pigmentation disorder treatments more effective and accessible. Aesthetic concerns drive many individuals to seek treatments that improve skin tone and appearance, contributing to the market's growth.
As per National Library of Medicine (NIH), in the Middle East, many patients with darker pigmentation (Fitzgerald skin types III-VI) are prone to develop post-inflammatory hyperpigmentation (PIH) due to acne. According to NIH, pigmentary disorders are among the top five most prevalent dermatological diagnoses among people of African descent. Dyschromias are the third most frequent dermatological diagnosis in Durban, KwaZulu-Natal, South Africa. In order of frequency, vitiligo, post-inflammatory hyperpigmentation, and melasma are the most prevalent subtypes of pigmentary disorders. Vitiligo, post inflammatory hyperpigmentation, and melasma are the three most prevalent pigmentary diagnoses among the 304 patients, mostly African women. Skin health awareness continues to grow in the LAMEA region, and the market is likely to expand further.
The Brazil market dominated the LAMEA Pigmentation Disorder Treatment Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $19.7 million by 2030. The Argentina market is showcasing a CAGR of 7.4% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 6.6% during (2023 - 2030).
Based on Type, the market is segmented into Vitiligo, Melasma, and Others. Based on Treatment, the market is segmented into Corticosteroids, Calcineurin Inhibitor, and Others. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies, & Online Pharmacies. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Worldwide Pigmentation Disorder Treatment Market is Projected to reach USD 1.2 Billion by 2030, at a CAGR of 4.8%
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Bausch Health Companies Inc, Glenmark Pharmaceuticals Limited, Obagi Cosmeceuticals LLC, AbbVie, Inc., Dermavant Sciences, Inc. (Roivant Sciences Ltd.), Incyte Corporation, Dr. Reddy’s Laboratories Ltd., Galderma S.A., Viatris, Inc. (Mylan N.V.), and Pfizer, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
By Treatment
- Corticosteroids
- Calcineurin Inhibitor
- Others
By Distribution Channel
- Drug Store & Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Bausch Health Companies Inc
- Glenmark Pharmaceuticals Limited
- Obagi Cosmeceuticals LLC
- AbbVie, Inc.
- Dermavant Sciences, Inc. (Roivant Sciences Ltd.)
- Incyte Corporation
- Dr.Reddy’s Laboratories Ltd.
- Galderma S.A.
- Viatris, Inc. (Mylan N.V.)
- Pfizer, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Pigmentation Disorder Treatment Market, by Type
1.4.2 LAMEA Pigmentation Disorder Treatment Market, by Treatment
1.4.3 LAMEA Pigmentation Disorder Treatment Market, by Distribution Channel
1.4.4 LAMEA Pigmentation Disorder Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. LAMEA Pigmentation Disorder Treatment Market, By Type
4.1 LAMEA Vitiligo Market, By Country
4.2 LAMEA Melasma Market, By Country
4.3 LAMEA Others Market, By Country
Chapter 5. LAMEA Pigmentation Disorder Treatment Market, By Treatment
5.1 LAMEA Corticosteroids Market, By Country
5.2 LAMEA Calcineurin Inhibitor Market, By Country
5.3 LAMEA Others Market, By Country
Chapter 6. LAMEA Pigmentation Disorder Treatment Market, By Distribution Channel
6.1 LAMEA Drug Store & Retail Pharmacies Market, By Country
6.2 LAMEA Hospital Pharmacies Market, By Country
6.3 LAMEA Online Pharmacies Market, By Country
Chapter 7. LAMEA Pigmentation Disorder Treatment Market, By Country
7.1 Brazil Pigmentation Disorder Treatment Market
7.1.1 Brazil Pigmentation Disorder Treatment Market, By Type
7.1.2 Brazil Pigmentation Disorder Treatment Market, By Treatment
7.1.3 Brazil Pigmentation Disorder Treatment Market, By Distribution Channel
7.2 Argentina Pigmentation Disorder Treatment Market
7.2.1 Argentina Pigmentation Disorder Treatment Market, By Type
7.2.2 Argentina Pigmentation Disorder Treatment Market, By Treatment
7.2.3 Argentina Pigmentation Disorder Treatment Market, By Distribution Channel
7.3 UAE Pigmentation Disorder Treatment Market
7.3.1 UAE Pigmentation Disorder Treatment Market, By Type
7.3.2 UAE Pigmentation Disorder Treatment Market, By Treatment
7.3.3 UAE Pigmentation Disorder Treatment Market, By Distribution Channel
7.4 Saudi Arabia Pigmentation Disorder Treatment Market
7.4.1 Saudi Arabia Pigmentation Disorder Treatment Market, By Type
7.4.2 Saudi Arabia Pigmentation Disorder Treatment Market, By Treatment
7.4.3 Saudi Arabia Pigmentation Disorder Treatment Market, By Distribution Channel
7.5 South Africa Pigmentation Disorder Treatment Market
7.5.1 South Africa Pigmentation Disorder Treatment Market, By Type
7.5.2 South Africa Pigmentation Disorder Treatment Market, By Treatment
7.5.3 South Africa Pigmentation Disorder Treatment Market, By Distribution Channel
7.6 Nigeria Pigmentation Disorder Treatment Market
7.6.1 Nigeria Pigmentation Disorder Treatment Market, By Type
7.6.2 Nigeria Pigmentation Disorder Treatment Market, By Treatment
7.6.3 Nigeria Pigmentation Disorder Treatment Market, By Distribution Channel
7.7 Rest of LAMEA Pigmentation Disorder Treatment Market
7.7.1 Rest of LAMEA Pigmentation Disorder Treatment Market, By Type
7.7.2 Rest of LAMEA Pigmentation Disorder Treatment Market, By Treatment
7.7.3 Rest of LAMEA Pigmentation Disorder Treatment Market, By Distribution Channel
Chapter 8. Company Profiles
8.1 Bausch Health Companies Inc
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 SWOT Analysis
8.2 Glenmark Pharmaceuticals Limited
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 SWOT Analysis
8.3 Obagi Cosmeceuticals LLC
8.3.1 Company Overview
8.3.2 SWOT Analysis
8.4 AbbVie, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.5 Dermavant Sciences, Inc. (Roivant Sciences Ltd.)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.5.4 SWOT Analysis
8.6 Incyte Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.6.3.1 Acquisition and Mergers:
8.6.3.2 Trials and Approvals:
8.6.4 SWOT Analysis
8.7 Dr. Reddy’s Laboratories Ltd.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Galderma S.A.
8.8.1 Company Overview
8.9 Viatris, Inc. (Mylan N.V.)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. Pfizer, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional & Segmental Analysis
8.10.4 Research & Development Expense
8.10.5 SWOT Analysis
TABLE 1 LAMEA Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
TABLE 2 LAMEA Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
TABLE 3 LAMEA Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
TABLE 4 LAMEA Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
TABLE 5 LAMEA Vitiligo Market, By Country, 2019 - 2022, USD Million
TABLE 6 LAMEA Vitiligo Market, By Country, 2023 - 2030, USD Million
TABLE 7 LAMEA Melasma Market, By Country, 2019 - 2022, USD Million
TABLE 8 LAMEA Melasma Market, By Country, 2023 - 2030, USD Million
TABLE 9 LAMEA Others Market, By Country, 2019 - 2022, USD Million
TABLE 10 LAMEA Others Market, By Country, 2023 - 2030, USD Million
TABLE 11 LAMEA Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
TABLE 12 LAMEA Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
TABLE 13 LAMEA Corticosteroids Market, By Country, 2019 - 2022, USD Million
TABLE 14 LAMEA Corticosteroids Market, By Country, 2023 - 2030, USD Million
TABLE 15 LAMEA Calcineurin Inhibitor Market, By Country, 2019 - 2022, USD Million
TABLE 16 LAMEA Calcineurin Inhibitor Market, By Country, 2023 - 2030, USD Million
TABLE 17 LAMEA Others Market, By Country, 2019 - 2022, USD Million
TABLE 18 LAMEA Others Market, By Country, 2023 - 2030, USD Million
TABLE 19 LAMEA Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
TABLE 20 LAMEA Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
TABLE 21 LAMEA Drug Store & Retail Pharmacies Market, By Country, 2019 - 2022, USD Million
TABLE 22 LAMEA Drug Store & Retail Pharmacies Market, By Country, 2023 - 2030, USD Million
TABLE 23 LAMEA Hospital Pharmacies Market, By Country, 2019 - 2022, USD Million
TABLE 24 LAMEA Hospital Pharmacies Market, By Country, 2023 - 2030, USD Million
TABLE 25 LAMEA Online Pharmacies Market, By Country, 2019 - 2022, USD Million
TABLE 26 LAMEA Online Pharmacies Market, By Country, 2023 - 2030, USD Million
TABLE 27 LAMEA Pigmentation Disorder Treatment Market, By Country, 2019 - 2022, USD Million
TABLE 28 LAMEA Pigmentation Disorder Treatment Market, By Country, 2023 - 2030, USD Million
TABLE 29 Brazil Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
TABLE 30 Brazil Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
TABLE 31 Brazil Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
TABLE 32 Brazil Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
TABLE 33 Brazil Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
TABLE 34 Brazil Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
TABLE 35 Brazil Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
TABLE 36 Brazil Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
TABLE 37 Argentina Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
TABLE 38 Argentina Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
TABLE 39 Argentina Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
TABLE 40 Argentina Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
TABLE 41 Argentina Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
TABLE 42 Argentina Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
TABLE 43 Argentina Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
TABLE 44 Argentina Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
TABLE 45 UAE Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
TABLE 46 UAE Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
TABLE 47 UAE Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
TABLE 48 UAE Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
TABLE 49 UAE Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
TABLE 50 UAE Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
TABLE 51 UAE Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
TABLE 52 UAE Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
TABLE 53 Saudi Arabia Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
TABLE 54 Saudi Arabia Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
TABLE 55 Saudi Arabia Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
TABLE 56 Saudi Arabia Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
TABLE 57 Saudi Arabia Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
TABLE 58 Saudi Arabia Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
TABLE 59 Saudi Arabia Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
TABLE 60 Saudi Arabia Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
TABLE 61 South Africa Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
TABLE 62 South Africa Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
TABLE 63 South Africa Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
TABLE 64 South Africa Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
TABLE 65 South Africa Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
TABLE 66 South Africa Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
TABLE 67 South Africa Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
TABLE 68 South Africa Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
TABLE 69 Nigeria Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
TABLE 70 Nigeria Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
TABLE 71 Nigeria Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
TABLE 72 Nigeria Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
TABLE 73 Nigeria Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
TABLE 74 Nigeria Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
TABLE 75 Nigeria Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
TABLE 76 Nigeria Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
TABLE 77 Rest of LAMEA Pigmentation Disorder Treatment Market, 2019 - 2022, USD Million
TABLE 78 Rest of LAMEA Pigmentation Disorder Treatment Market, 2023 - 2030, USD Million
TABLE 79 Rest of LAMEA Pigmentation Disorder Treatment Market, By Type, 2019 - 2022, USD Million
TABLE 80 Rest of LAMEA Pigmentation Disorder Treatment Market, By Type, 2023 - 2030, USD Million
TABLE 81 Rest of LAMEA Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2022, USD Million
TABLE 82 Rest of LAMEA Pigmentation Disorder Treatment Market, By Treatment, 2023 - 2030, USD Million
TABLE 83 Rest of LAMEA Pigmentation Disorder Treatment Market, By Distribution Channel, 2019 - 2022, USD Million
TABLE 84 Rest of LAMEA Pigmentation Disorder Treatment Market, By Distribution Channel, 2023 - 2030, USD Million
TABLE 85 Key Information – Bausch Health Companies Inc
TABLE 86 Key Information – Glenmark Pharmaceuticals Limited
TABLE 87 Key Information – Obagi Cosmeceuticals LLC
TABLE 88 Key Information – AbbVie, Inc.
TABLE 89 Key Information – Dermavant Sciences, Inc.
TABLE 90 Key Information – Incyte Corporation
TABLE 91 Key Information – Dr. Reddy’s Laboratories Ltd.
TABLE 92 Key Information – Galderma S.A.
TABLE 93 Key Information – Viatris, Inc.
TABLE 94 Key Information – Pfizer, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Pigmentation Disorder Treatment Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting the Pigmentation Disorder Treatment Market
FIG 4 Porter’s Five Forces Analysis – Pigmentation Disorder Treatment Market
FIG 5 LAMEA Pigmentation Disorder Treatment Market share, By Type, 2022
FIG 6 LAMEA Pigmentation Disorder Treatment Market share, By Type, 2030
FIG 7 LAMEA Pigmentation Disorder Treatment Market, By Type, 2019 - 2030, USD Million
FIG 8 LAMEA Pigmentation Disorder Treatment Market share, By Treatment, 2022
FIG 9 LAMEA Pigmentation Disorder Treatment Market share, By Treatment, 2030
FIG 10 LAMEA Pigmentation Disorder Treatment Market, By Treatment, 2019 - 2030, USD Million
FIG 11 LAMEA Pigmentation Disorder Treatment Market share, By Distribution Channel, 2022
FIG 12 LAMEA Pigmentation Disorder Treatment Market share, By Distribution Channel, 2030
FIG 13 LAMEA Pigmentation Disorder Treatment Market, By Distribution Channel, 2019- 2030, USD Million
FIG 14 LAMEA Pigmentation Disorder Treatment Market share, By Country, 2022
FIG 15 LAMEA Pigmentation Disorder Treatment Market share, By Country, 2030
FIG 16 LAMEA Pigmentation Disorder Treatment Market, By Country, 2019 - 2030, USD Million
FIG 17 SWOT Analysis: Bausch Health Companies Inc
FIG 18 SWOT Analysis: Glenmark Pharmaceuticals Limited
FIG 19 SWOT Analysis: Obagi Cosmeceuticals LLC
FIG 20 SWOT Analysis: Dermavant Sciences, Inc.
FIG 21 SWOT Analysis: Incyte Corporation
FIG 22 SWOT Analysis: Dr. Reddy’s Laboratories Ltd.
FIG 23 SWOT Analysis: Viatris, Inc.
FIG 24 SWOT Analysis: Pfizer, Inc.